Peripheral Arterial Disease in the Elderly

Overview

Journal Clin Interv Aging

Publisher Dove Medical Press

Specialty Geriatrics

Date 2008 Jan 30

PMID 18225466

Citations 18

Authors

Wilbert S Aronow

Affiliations

Soon will be listed here.

Abstract

Smoking should be stopped and hypertension, diabetes mellitus, dyslipidemia, and hypothyroidism treated in elderly patients with peripheral arterial disease (PAD) of the lower extremities. Statins reduce the incidence of intermittent claudication and improve exercise duration until the onset of intermittent claudication in patients with PAD and hypercholesterolemia. Antiplatelet drugs such as aspirin or clopidogrel, especially clopidogrel, angiotensin-converting enzyme inhibitors, and statins should be given to all elderly patients with PAD without contraindications to these drugs. Beta blockers should be given if coronary artery disease is present. Exercise rehabilitation programs and cilostazol increase exercise time until intermittent claudication develops. Chelation therapy should be avoided. Indications for lower extremity percutaneous transluminal angioplasty or bypass surgery are (1) incapacitating claudication in patients interfering with work or lifestyle; (2) limb salvage in patients with limb-threatening ischemia as manifested by rest pain, nonhealing ulcers, and/or infection or gangrene; and (3) vasculogenic impotence.

Citing Articles

Importance of Successful Revascularization in Acute Limb Ischemia: Sub-Analysis From the RESCUE ALI Trial.

Haraguchi T, Tan M, Uchida D, Dannoura Y, Shibata T, Iwata S Catheter Cardiovasc Interv. 2024; 105(1):211-218.

PMID: 39627985 PMC: 11694559. DOI: 10.1002/ccd.31319.

The Use of Clot Strength as a Predictor of Thrombosis in Peripheral Artery Disease.

Suarez Ferreira S, Agrawal A, Lee I, Rodriguez A, Cieri I, Young E Ann Vasc Surg. 2024; 109:273-283.

PMID: 39069123 PMC: 11524772. DOI: 10.1016/j.avsg.2024.06.041.

A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients-A Review PART II-Pharmacological Approach for Management of Elderly Patients with Peripheral Atherosclerotic Lesions outside Coronary....

Piechocki M, Przewlocki T, Pieniazek P, Trystula M, Podolec J, Kablak-Ziembicka A J Clin Med. 2024; 13(5).

PMID: 38592348 PMC: 10934701. DOI: 10.3390/jcm13051508.

In Association with Other Risk Factors, Smoking Is the Main Predictor for Lower Transcutaneous Oxygen Pressure in Type 2 Diabetes.

Bulum T, Brkljacic N, Ticinovic Ivancic A, cavlovic M, Prkacin I, Tomic M Biomedicines. 2024; 12(2).

PMID: 38397984 PMC: 10886561. DOI: 10.3390/biomedicines12020381.

Left subclavian artery coverage during endovascular repair of thoracic aorta injury in trauma and non-trauma patients.

Grigorian A, Lewis M, Wlodarczyk J, Chien C, Park T, Demetriades D Eur J Trauma Emerg Surg. 2022; 48(6):4425-4429.

PMID: 35713681 DOI: 10.1007/s00068-022-02027-5.

References

Aronow W, Ahn C, Weiss M, Babu S . Relation of increased hemoglobin A(1c) levels to severity of peripheral arterial disease in patients with diabetes mellitus. Am J Cardiol. 2007; 99(10):1468-9. DOI: 10.1016/j.amjcard.2006.12.085. View

Dormandy J, Rutherford R . Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000; 31(1 Pt 2):S1-S296. View

De Frang R, Taylor Jr L, Porter J . Basic data related to amputations. Ann Vasc Surg. 1991; 5(2):202-7. DOI: 10.1007/BF02016758. View

Criqui M, Fronek A, Barrett-Connor E, Klauber M, Gabriel S, Goodman D . The prevalence of peripheral arterial disease in a defined population. Circulation. 1985; 71(3):510-5. DOI: 10.1161/01.cir.71.3.510. View

Heart Protection Study Collaborative Group . Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial. Lancet. 2011; 378(9808):2013-2020. PMC: 3242163. DOI: 10.1016/S0140-6736(11)61125-2. View

McDermott M, Greenland P, Liu K, Guralnik J, Celic L, Criqui M . The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med. 2002; 136(12):873-83. DOI: 10.7326/0003-4819-136-12-200206180-00008. View

Hiatt W . Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001; 344(21):1608-21. DOI: 10.1056/NEJM200105243442108. View

Newman A, Tyrrell K, Kuller L . Mortality over four years in SHEP participants with a low ankle-arm index. J Am Geriatr Soc. 1997; 45(12):1472-8. DOI: 10.1111/j.1532-5415.1997.tb03198.x. View

Smith Jr S, Blair S, Bonow R, Brass L, Cerqueira M, Dracup K . AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 2001; 38(5):1581-3. DOI: 10.1016/s0735-1097(01)01682-5. View

10.

Mya M, Aronow W . Increased prevalence of peripheral arterial disease in older men and women with subclinical hypothyroidism. J Gerontol A Biol Sci Med Sci. 2003; 58(1):68-9. DOI: 10.1093/gerona/58.1.m68. View

11.

DAWSON D, CUTLER B, Hiatt W, Hobson 2nd R, Martin J, Bortey E . A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med. 2000; 109(7):523-30. DOI: 10.1016/s0002-9343(00)00569-6. View

12.

Gardner A, Katzel L, Sorkin J, Killewich L, Ryan A, Flinn W . Improved functional outcomes following exercise rehabilitation in patients with intermittent claudication. J Gerontol A Biol Sci Med Sci. 2000; 55(10):M570-7. DOI: 10.1093/gerona/55.10.m570. View

13.

Grundy S, Cleeman J, Merz C, Brewer Jr H, Clark L, Hunninghake D . Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004; 110(2):227-39. DOI: 10.1161/01.CIR.0000133317.49796.0E. View

14.

Sukhija R, Yalamanchili K, Aronow W . Prevalence of left main coronary artery disease, of three- or four-vessel coronary artery disease, and of obstructive coronary artery disease in patients with and without peripheral arterial disease undergoing coronary angiography for suspected.... Am J Cardiol. 2003; 92(3):304-5. DOI: 10.1016/s0002-9149(03)00632-5. View

15.

Lehert P, Comte S, Gamand S, Brown T . Naftidrofuryl in intermittent claudication: a retrospective analysis. J Cardiovasc Pharmacol. 1994; 23 Suppl 3:S48-52. View

16.

Myers K, King R, Scott D, Johnson N, Morris P . The effect of smoking on the late patency of arterial reconstructions in the legs. Br J Surg. 1978; 65(4):267-71. DOI: 10.1002/bjs.1800650415. View

17.

Money S, HERD J, Isaacsohn J, Davidson M, Cutler B, HECKMAN J . Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. J Vasc Surg. 1998; 27(2):267-74; discussion 274-5. DOI: 10.1016/s0741-5214(98)70357-x. View

18.

Hirsch A, Haskal Z, Hertzer N, Bakal C, Creager M, Halperin J . ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for.... Circulation. 2006; 113(11):e463-654. DOI: 10.1161/CIRCULATIONAHA.106.174526. View

19.

Bhatt D, Flather M, Hacke W, Berger P, Black H, Boden W . Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol. 2007; 49(19):1982-8. DOI: 10.1016/j.jacc.2007.03.025. View

20.

MALINOW M, Kang S, Taylor L, Wong P, Coull B, INAHARA T . Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation. 1989; 79(6):1180-8. DOI: 10.1161/01.cir.79.6.1180. View